RACHEL STERLING: Open Payments
NPI 1902407935 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,986 in 46 payments from 12 companies in 2025. Trend: 2023 $1,124 · 2024 $4,357 · 2025 $1,986
Food & beverage: $1,986
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 9 | $821 |
| ABIOMED | 12 | $315 |
| CVRx, Inc. | 10 | $200 |
| AstraZeneca Pharmaceuticals LP | 3 | $153 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $125 |
| Medtronic, Inc. | 1 | $95 |
| United Therapeutics Corporation | 4 | $93 |
| Fresenius USA Marketing, Inc. | 1 | $69 |
| Merck Sharp & Dohme LLC | 2 | $39 |
| Alnylam Pharmaceuticals Inc. | 1 | $29 |
Products named: CARDIOMEMS, 2ND GEN CENTRIMAG PRIMARY CONSOLE, Barostim Neo System, Kerendia, LOKELMA, VITALFLOW CONSOLE, NOVALUNG SYSTEM, Tyvaso.
Industry payments across TX — which companies pay providers there.
